AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis

Non-random gains of chromosome 5p have been observed in clinically aggressive gastrointestinal stromal tumors, whereas the driving oncogenes on 5p remain to be characterized. We used an integrative genomic and functional approach to identify amplified oncogenes on 5p and to evaluate the relevance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chien-Feng, Chen, Li-Tzong, Lan, Jui, Chou, Fong-Fu, Lin, Ching-Yih, Chen, Yen-Yang, Chen, Tzu-Ju, Li, Shau-Hsuan, Yu, Shih-Chen, Fang, Fu-Ming, Tai, Hui-Chun, Huang, Hsuan-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294386/
https://www.ncbi.nlm.nih.gov/pubmed/25473890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294386/
https://www.ncbi.nlm.nih.gov/pubmed/25473890

Ejemplares similares